News & Events
-
November 1, 2021
C-Path’s Quantitative Medicine Team to Lead Trainee Tutorial at American Conference on Pharmacometrics
On November 12, 2021 Jagdeep Podichetty, Director of Predictive Analytics within Quantitative Medicine program at Critical Path Institute (C-Path) will chair a trainee tutorial at the American Conference on Pharmacometrics (ACoP). The trainee tutorial titled Application of Machine Learning in Drug Development with Regulatory Considerations will expose trainees to various drug development case studies that... -
April 26, 2021
C-Path Selects New Leaders of Data Science and Quantitative Medicine
TUCSON, Ariz., April 26, 2021 — Critical Path Institute (C-Path) has named Amanda J. Borens, M.S., as Executive Director of Data Science within C-Path’s Data Collaboration Center (DCC), and Jackson Burton, Ph.D., as Executive Director of C-Path’s Quantitative Medicine Program. Amanda Borens, MSc Executive Director of Data Science Borens has been with C-Path for nearly... -
December 2, 2020
C-Path Quantitative Medicine Program Awarded FDA Contract to Develop Tools for Neuroscience Diseases
TUCSON, Ariz., December 2, 2020 — The Critical Path Institute (C-Path) today announced it has been awarded a U.S. Food and Drug Administration (FDA) contract in support of the development of open-source tools to improve the efficiency of trial design for three neuroscience diseases: Alzheimer’s disease (AD), Parkinson’s disease (PD) and Duchenne muscular dystrophy... -
March 12, 2020
C-Path Appoints Dr. Klaus Romero as Chief Science Officer
The Critical Path Institute (C-Path) today announced the appointment of Klaus Romero, M.D., M.S., F.C.P., as its new Chief Science Officer (CSO) effective April 1, 2020. Dr. Romero, a clinical pharmacologist and epidemiologist with more than 17 years combined experience in academic and pharmaceutical clinical research, translational sciences, pharmacometrics, modeling and simulation and pharmacoepidemiology, has been with C-Path since December 2007. His most recent role has been as Executive Director of Clinical Pharmacology and Quantitative Medicine. He will continue in dual roles as CSO and head of the Quantitative Medicine Program.